Titre : Confiance

Confiance : Questions médicales fréquentes

Termes MeSH sélectionnés :

C-Reactive Protein
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Confiance : Questions médicales les plus fréquentes", "headline": "Confiance : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Confiance : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-22", "dateModified": "2025-04-16", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Confiance" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Relations interpersonnelles", "url": "https://questionsmedicales.fr/mesh/D007398", "about": { "@type": "MedicalCondition", "name": "Relations interpersonnelles", "code": { "@type": "MedicalCode", "code": "D007398", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F01.829.401" } } }, "about": { "@type": "MedicalCondition", "name": "Confiance", "alternateName": "Trust", "code": { "@type": "MedicalCode", "code": "D035502", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Peter Fonagy", "url": "https://questionsmedicales.fr/author/Peter%20Fonagy", "affiliation": { "@type": "Organization", "name": "Anna Freud National Centre for Children and Families, London, United Kingdom." } }, { "@type": "Person", "name": "H Holden Thorp", "url": "https://questionsmedicales.fr/author/H%20Holden%20Thorp", "affiliation": { "@type": "Organization", "name": "H. Holden Thorp Editor-in-Chief, Science journals." } }, { "@type": "Person", "name": "Angelo Cangelosi", "url": "https://questionsmedicales.fr/author/Angelo%20Cangelosi", "affiliation": { "@type": "Organization", "name": "1 Cognitive Robotics Laboratory, The University of Manchester , Manchester, M13 9PL , UK." } }, { "@type": "Person", "name": "Jonathan H Marks", "url": "https://questionsmedicales.fr/author/Jonathan%20H%20Marks", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "An-Sofie Vanhouche", "url": "https://questionsmedicales.fr/author/An-Sofie%20Vanhouche", "affiliation": { "@type": "Organization", "name": "Postdoctoral Researcher at the Crime and Society Research Group of the Vrije Universiteit Brussel, Belgium. Electronic address: An-Sofie.Vanhouche@vub.be." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "C-Reactive Protein as a Prognostic Biomarker for Gynecologic Cancers: A Meta-Analysis.", "datePublished": "2022-10-11", "url": "https://questionsmedicales.fr/article/36268143", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1155/2022/6833078" } }, { "@type": "ScholarlyArticle", "name": "Regulation of Conformational Changes in C-reactive Protein Alters its Bioactivity.", "datePublished": "2022-08-23", "url": "https://questionsmedicales.fr/article/35997934", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12013-022-01089-x" } }, { "@type": "ScholarlyArticle", "name": "A rapid fluorescent aptasensor for point-of-care detection of C-reactive protein.", "datePublished": "2022-06-04", "url": "https://questionsmedicales.fr/article/35714415", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.talanta.2022.123661" } }, { "@type": "ScholarlyArticle", "name": "C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis.", "datePublished": "2022-07-09", "url": "https://questionsmedicales.fr/article/35821191", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ejim.2022.07.001" } }, { "@type": "ScholarlyArticle", "name": "C-reactive protein to lymphocyte count ratio is a promising novel marker in hepatitis C infection: the clear hep-c study.", "datePublished": "2022-06-24", "url": "https://questionsmedicales.fr/article/35766701", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/1806-9282.20220236" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Comportement et mécanismes comportementaux", "item": "https://questionsmedicales.fr/mesh/D001520" }, { "@type": "ListItem", "position": 3, "name": "Relations interpersonnelles", "item": "https://questionsmedicales.fr/mesh/D007398" }, { "@type": "ListItem", "position": 4, "name": "Confiance", "item": "https://questionsmedicales.fr/mesh/D035502" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Confiance - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Confiance", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Confiance", "description": "Comment évaluer la confiance d'un patient ?\nQuels facteurs influencent la confiance des patients ?\nLa confiance affecte-t-elle l'adhésion au traitement ?\nComment mesurer la confiance dans les soins de santé ?\nQuel rôle joue la transparence dans la confiance ?", "url": "https://questionsmedicales.fr/mesh/D035502?mesh_terms=C-Reactive+Protein&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Confiance", "description": "Quels symptômes indiquent une perte de confiance ?\nComment la méfiance se manifeste-t-elle chez un patient ?\nQuels signes montrent une confiance élevée ?\nLa confiance peut-elle affecter le bien-être psychologique ?\nQuels symptômes psychologiques sont liés à la méfiance ?", "url": "https://questionsmedicales.fr/mesh/D035502?mesh_terms=C-Reactive+Protein&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Confiance", "description": "Comment prévenir la méfiance envers les médecins ?\nQuel rôle joue l'éducation des patients dans la confiance ?\nComment les politiques de santé influencent-elles la confiance ?\nLes campagnes de sensibilisation peuvent-elles aider ?\nComment la technologie influence-t-elle la confiance ?", "url": "https://questionsmedicales.fr/mesh/D035502?mesh_terms=C-Reactive+Protein&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Confiance", "description": "Comment améliorer la confiance dans le traitement ?\nLes traitements alternatifs affectent-ils la confiance ?\nComment la confiance influence-t-elle les résultats des traitements ?\nLes effets secondaires affectent-ils la confiance ?\nComment les médecins peuvent-ils renforcer la confiance ?", "url": "https://questionsmedicales.fr/mesh/D035502?mesh_terms=C-Reactive+Protein&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Confiance", "description": "Quelles complications peuvent résulter d'une faible confiance ?\nComment la méfiance affecte-t-elle les soins préventifs ?\nLes complications psychologiques sont-elles liées à la confiance ?\nComment la confiance influence-t-elle les résultats cliniques ?\nQuelles sont les conséquences d'une mauvaise communication ?", "url": "https://questionsmedicales.fr/mesh/D035502?mesh_terms=C-Reactive+Protein&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Confiance", "description": "Quels facteurs augmentent le risque de méfiance ?\nL'âge influence-t-il la confiance des patients ?\nLes antécédents médicaux affectent-ils la confiance ?\nLe niveau d'éducation influence-t-il la confiance ?\nLes différences culturelles affectent-elles la confiance ?", "url": "https://questionsmedicales.fr/mesh/D035502?mesh_terms=C-Reactive+Protein&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer la confiance d'un patient ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des questionnaires et des entretiens peuvent mesurer la confiance du patient envers le médecin." } }, { "@type": "Question", "name": "Quels facteurs influencent la confiance des patients ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'expérience antérieure, la communication et la réputation du médecin influencent la confiance." } }, { "@type": "Question", "name": "La confiance affecte-t-elle l'adhésion au traitement ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une confiance élevée augmente l'adhésion aux traitements prescrits par le médecin." } }, { "@type": "Question", "name": "Comment mesurer la confiance dans les soins de santé ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des échelles de mesure et des enquêtes peuvent évaluer la confiance dans les soins de santé." } }, { "@type": "Question", "name": "Quel rôle joue la transparence dans la confiance ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "La transparence des informations médicales renforce la confiance entre le patient et le médecin." } }, { "@type": "Question", "name": "Quels symptômes indiquent une perte de confiance ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "L'anxiété, la méfiance et la réticence à poser des questions peuvent signaler une perte de confiance." } }, { "@type": "Question", "name": "Comment la méfiance se manifeste-t-elle chez un patient ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "La méfiance peut se manifester par des doutes sur les diagnostics ou les traitements proposés." } }, { "@type": "Question", "name": "Quels signes montrent une confiance élevée ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Un patient qui pose des questions et suit les recommandations montre une confiance élevée." } }, { "@type": "Question", "name": "La confiance peut-elle affecter le bien-être psychologique ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une faible confiance peut entraîner du stress et affecter le bien-être psychologique." } }, { "@type": "Question", "name": "Quels symptômes psychologiques sont liés à la méfiance ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "La méfiance peut entraîner des symptômes comme la dépression et l'anxiété chez les patients." } }, { "@type": "Question", "name": "Comment prévenir la méfiance envers les médecins ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La formation continue des médecins et la transparence des soins peuvent prévenir la méfiance." } }, { "@type": "Question", "name": "Quel rôle joue l'éducation des patients dans la confiance ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation des patients sur leur santé renforce leur confiance envers les professionnels de santé." } }, { "@type": "Question", "name": "Comment les politiques de santé influencent-elles la confiance ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des politiques de santé transparentes et éthiques renforcent la confiance du public dans le système de santé." } }, { "@type": "Question", "name": "Les campagnes de sensibilisation peuvent-elles aider ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les campagnes de sensibilisation sur la santé renforcent la confiance des patients dans les soins." } }, { "@type": "Question", "name": "Comment la technologie influence-t-elle la confiance ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "La technologie peut renforcer la confiance par l'accès à l'information et la communication améliorée." } }, { "@type": "Question", "name": "Comment améliorer la confiance dans le traitement ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Une communication claire et des explications détaillées peuvent améliorer la confiance dans le traitement." } }, { "@type": "Question", "name": "Les traitements alternatifs affectent-ils la confiance ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'utilisation de traitements alternatifs peut diminuer la confiance dans les soins conventionnels." } }, { "@type": "Question", "name": "Comment la confiance influence-t-elle les résultats des traitements ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une confiance élevée peut améliorer l'efficacité des traitements et la satisfaction des patients." } }, { "@type": "Question", "name": "Les effets secondaires affectent-ils la confiance ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les effets secondaires peuvent diminuer la confiance des patients dans le traitement prescrit." } }, { "@type": "Question", "name": "Comment les médecins peuvent-ils renforcer la confiance ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les médecins peuvent renforcer la confiance par l'écoute active et la validation des préoccupations des patients." } }, { "@type": "Question", "name": "Quelles complications peuvent résulter d'une faible confiance ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Une faible confiance peut entraîner une mauvaise adhésion aux traitements et des complications de santé." } }, { "@type": "Question", "name": "Comment la méfiance affecte-t-elle les soins préventifs ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "La méfiance peut réduire l'utilisation des soins préventifs, augmentant le risque de maladies." } }, { "@type": "Question", "name": "Les complications psychologiques sont-elles liées à la confiance ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une faible confiance peut entraîner des complications psychologiques comme l'anxiété et la dépression." } }, { "@type": "Question", "name": "Comment la confiance influence-t-elle les résultats cliniques ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Une confiance élevée est associée à de meilleurs résultats cliniques et à une satisfaction accrue." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une mauvaise communication ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une mauvaise communication peut entraîner des malentendus et diminuer la confiance entre patient et médecin." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de méfiance ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des expériences négatives antérieures et un manque de communication augmentent le risque de méfiance." } }, { "@type": "Question", "name": "L'âge influence-t-il la confiance des patients ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients plus âgés peuvent avoir des niveaux de confiance différents en fonction de leurs expériences." } }, { "@type": "Question", "name": "Les antécédents médicaux affectent-ils la confiance ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de soins insatisfaisants peuvent diminuer la confiance dans les soins futurs." } }, { "@type": "Question", "name": "Le niveau d'éducation influence-t-il la confiance ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un niveau d'éducation plus élevé est souvent associé à une meilleure compréhension et confiance." } }, { "@type": "Question", "name": "Les différences culturelles affectent-elles la confiance ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les différences culturelles peuvent influencer la perception de la confiance dans les soins de santé." } } ] } ] }

Sources (10000 au total)

C-Reactive Protein as a Prognostic Biomarker for Gynecologic Cancers: A Meta-Analysis.

The prognostic role of CRP (C-reactive protein) in gynecological tumors has been previously reported in individual studies, but whether CRP can be used as a separate potential prognostic factor has no... A systematic search was carried out to find the literature evaluating the predictive role of CRP in the prognosis of gynecological cancer patients. For the purpose of determining the relationship betw... A total of 19 studies, including 4062 patients, were analyzed retrospectively. The FIGO stage was related to the CRP level (OR = 0.43, 95% CI: 0.19-1.00). Age, lymph node metastasis, and histological ... CRP may be utilized as a prognostic indicator for a variety of gynecologic malignancies, including cervical cancer, ovarian cancer, endometrial cancer, and vulvar cancer....

C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis.

To evaluate the association between C-reactive protein (CRP) and 10-year risk of cardiovascular (CV) events using the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis (ERS-RA), b... ERS-RA was calculated in 1,251 "Cardiovascular Obesity and Rheumatic Disease Study (CORDIS)" database patients [(age 60.4(9.3) years; 78% female; disease duration, 11.6(8) years; CDAI, 9(9); CRP, 6.8(... The mean (SD) 10-year risk of CV events was 12.9% (10). After adjusting for the use of DMARDs and biologics, CRP concentrations were significantly associated with 10-year risk of CV events (coefficien... In a large cohort of RA patients without previous cardiovascular events, a 20 mg/L increase in CRP concentrations was associated with a 1% increase in 10-year risk of CV events. This suggests that act...

C-reactive protein to lymphocyte count ratio is a promising novel marker in hepatitis C infection: the clear hep-c study.

Chronic hepatitis C (CHC) is one of the most important health problems affecting the significant rate of world population and it may lead to cirrhosis and hepatocellular carcinoma. C-reactive protein ... Patients with CHC infection who visited outpatient and inpatient internal medicine clinics of our institution between January 2021 and December 2021 were enrolled to this retrospective study. CLR of t... Median CLR of CHC and control subjects was 2.61 (5.13%) and 0.31 (0.37%), respectively. CLR of the CHC group was significantly increased compared to the CLR of the controls (p<0.001). There was a sign... Increased CLR in patients with CHC may be an alarming finding of liver fibrosis, as CLR is associated with both CHC and hepatic fibrosis....

Serum C-reactive protein levels are associated with clinical pregnancy rate after

To assess whether low-grade inflammation, measured by serum high-sensitivity C-reactive protein (hsCRP) levels, is associated with... A retrospective study.... University-affiliated IVF center.... In the present study, 875 women of normal weight who underwent their first fresh embryo transfer (ET) cycles for IVF treatment were divided into three groups according to serum concentrations of hsCRP... Serum from women undergoing IVF was collected on days 2-4 of a spontaneous menstrual cycle prior to the commencement of ovarian stimulation.... The IVF outcomes included implantation, biochemical pregnancy, clinical pregnancy, miscarriage and live birth rates.... The women were divided into three groups according to the baseline serum levels of hsCRP as follows: low hsCRP (<1 mg/L; n=517), medium hsCRP (1-3 mg/L; n= 270), high hsCRP (>3 mg/L; n=88). The matern... Among women of normal weight undergoing their first IVF treatment, it was found that low-grade inflammation was associated with reduced clinical pregnancy and live birth rates following fresh ET cycle...

Mortality Risk in Pediatric Sepsis Based on C-reactive Protein and Ferritin Levels.

Interest in using bedside C-reactive protein (CRP) and ferritin levels to identify patients with hyperinflammatory sepsis who might benefit from anti-inflammatory therapies has piqued with the COVID-1... A prospective, observational cohort study.... Children with sepsis and organ failure in nine pediatric intensive care units in the United States.... Two hundred and fifty-five children were enrolled. Five distinct clinical multi-trajectory groups were identified. Plasma CRP (mg/dL), ferritin (ng/mL), and 31 cytokine levels were measured at two tim... Group 1 had normal CRP and ferritin levels ( n = 8; 0% mortality); Group 2 had high CRP levels that became normal, with normal ferritin levels throughout ( n = 80; 5% mortality); Group 3 had high ferr... Bedside CRP and ferritin levels can be used together to distinguish groups of children with sepsis who have different systemic inflammation cytokine responses and mortality risks. These data suggest f...